| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1363361 | Bioorganic & Medicinal Chemistry Letters | 2010 | 6 Pages |
Libraries of 1-methyl-2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-ones/oximes/O-methyloximes 1–14/15–28/29–42 and 7-methyl-2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-ones/oximes/O-methyloximes 43–48/49–54/55–60 were synthesized and their stereochemistry was established by 1D/2D NMR spectral and single crystal XRD studies. All the synthesized oximes and oxime ethers were screened for their in vitro antimicrobial activity against a panel of pathogenic bacteria (Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa) and fungi (Candida albicans, Candida parapsilosis, Aspergillus niger and Cryptococcus neoformans) using Gentamicin and Fluconazole as standards, respectively. From the SAR profile, the lead molecules were identified.
Graphical abstractLibraries of 1- and 7-methyl-2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-ones/oximes/O-methyloximes were synthesized and unambiguously characterized by 1D/2D NMR and single crystal XRD data. All the synthesized oximes and oxime ethers were evaluated for their in vitro antimicrobial activity.Figure optionsDownload full-size imageDownload as PowerPoint slide
